Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Women with lichen planopilaris and frontal fibrosing alopecia often have other health issues like hypothyroidism and lupus.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Lindera aggregata has many beneficial compounds that can help prevent and manage diseases.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

Higher inflammation markers are linked to more severe alopecia areata.

Alopecia areata in Dubai mostly affects men, often involves autoimmune disorders, and has high healthcare costs, especially for psychological issues.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Improved oral hygiene and dietary changes can help manage black hairy tongue syndrome.

The woman has Discoid Lupus Erythematosus and needs specialist care.

Hydroxychloroquine may help delay skin damage in lupus patients.

Human mesenchymal stem cells show promise for treating skin diseases, but more research is needed to improve treatments.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

Topical peptides may offer safer, effective pain relief and healing for wounds.

Mycophenolic acid effectively improved hair and nail growth in a lupus patient.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Digital gangrene can be an unusual first sign of late-onset lupus.

Wounding may stimulate hair growth, but more research is needed to confirm the safety and effectiveness of related treatments.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.